These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3126342)

  • 1. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
    Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
    Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.
    Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W
    Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [rt-PA in extracardiac thromboembolic vascular occlusions].
    Cortellaro M; Cofrancesco E; Polli EE
    Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
    Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
    Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
    Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
    Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
    Schranz D; Haugwitz D; Zimmer B; Schumacher R
    Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
    Reim M; Bertram B; Wolf S
    Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
    Marder VJ; Brenner B; Totterman S; Francis CW; Rubin R; Rao AK; Kessler CM; Kwaan HC; Sharma GV; Fong KL
    J Lab Clin Med; 1992 May; 119(5):485-95. PubMed ID: 1583404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.
    Emeis JJ; Verheijen JH
    Arzneimittelforschung; 1992 Mar; 42(3):358-62. PubMed ID: 1497699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial.
    Bounameaux H; Banga JD; Bluhmki E; Coccheri S; Fiessinger JN; Haarmann W; Lockner D; Mahler F; Ninet J; Schneider PA
    Thromb Haemost; 1992 Mar; 67(3):306-9. PubMed ID: 1641820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinolytic therapy of deep leg- and pelvic vein thrombosis with various dosages of rt-PA--a pilot study].
    Doder A; Pilger E; Obernosterer A; Decrinis M; Tischler R; Lafer M; Stark G; Aschauer M
    Vasa Suppl; 1992; 37():41-2. PubMed ID: 1481095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.